Classification and Diagnosis of Dm Isd Workshop 2014

Embed Size (px)

Citation preview

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    1/42

    DIAGNOSIS ANDCLASSIFICATION OFDIABETES MELLITUS

    LEILANI A. BALDEVISO, M.D.,DPCP

    INTERNAL MEDICINE-DIABETES

    ISDFI-FACULTY

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    2/42

    Learning Obje!i"e#

    Defne the criteria or diagnosingDefne the criteria or diagnosing

    diabetesdiabetes

    Enumerate and dierentiate theEnumerate and dierentiate thetypes o diabetestypes o diabetes

    Identiy patient risk actors orIdentiy patient risk actors or

    diabetesdiabetes Cite screening recommendationsCite screening recommendations

    or patients at riskor patients at risk

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    3/42

    A $e!ab%&i'i#%r'er (re#ene %) *+(erg&+e$ia

    'e !% 'e)e!i"e in#&in #ere!i%n, in#&in

    a!i%n %r b%!* re#&!ing in 'e)e!# in arb%*+'ra!e,

    (r%!ein an' )a! $e!ab%&i#$.

    Associated with long-term seuelaeAssociated with long-term seuelaeaecting! kidney" eye" ner#es" heart andaecting! kidney" eye" ner#es" heart and

    blood #essels$blood #essels$

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    4/42

    Re"i#i%n# in Diabe!e# C&a##ia!i%nTer$in%&%g+

    /0/-- NDDG //1---ADA

    T*e !er$2j"eni&e

    %n#e!3 an' 2 a'&!%n#e!3 'iabe!e#4ere 'i#ar'e' a#ina((r%(ria!e an'

    re!er$e' 2in#&in-'e(en'en! 'iabe!e#$e&&i!# 5IDDM63an' 2n%n-in#&in-'e(en'en! 'iabe!e#

    $e&&i!# 5NIDDM63,

    T*e !er$# 2 in#&in- 'e(en'en!3 an' 2n%n-

    in#&in- 'e(en'en! an' !*eirar%n+$#

    4ere e&i$ina!e' a#%n)#ing

    an' !rea!$en!-ba#e'ra!*er !*e

    e!i%&%g+-ba#e'

    T*e !er$# 2!+(e 3

    an'!+(e 73 'iabe!e#

    4erere!aine', #ing

    arabi

    n$era ra!*er!*an

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    5/42

    2T8E DIABETICS OF TOMORRO99ILL COME FROM T8E C8ILDREN OF

    TODAY3

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    6/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    7/42

    Diabetes Prevalence in the Philippines

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    8/42

    C&a##i S+$(!%$# %)

    Diabe!e# %olyuria%olyuria

    %olydipsia%olydipsia &ne'plained weight loss&ne'plained weight loss

    (eport o the E'pert Committee on the Diagnosis and Classifcation o Diabetes )ellitus$

    Diabetes Care *++, *./0uppl 12!s3-s*+

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    9/42

    Diagn%#i# %) Diabe!e#

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    10/42

    Suggested Algorithm forSuggested Algorithm for

    Diagnosing DiabetesDiagnosing Diabetes

    Based on: Report of the Expert Committee on theBased on: Report of the Expert Committee on the

    Diagnosis and Classification of Diabetes Mellitus.Diagnosis and Classification of Diabetes Mellitus.

    Diabetes Care 2003 2!"#uppl $%: s$2 &D&.Diabetes Care 2003 2!"#uppl $%: s$2 &D&.

    #creening for '(pe 2 Diabetes. Diabetes Care 2003#creening for '(pe 2 Diabetes. Diabetes Care 2003

    2!"#uppl $%: s2$)s2*%2!"#uppl $%: s2$)s2*%

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    11/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    12/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    13/42

    33%33%NormalNormal

    33%33%IGTIGT

    33%33%DMDM

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    14/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    15/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    16/42

    Prediabetes

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    17/42

    Classification of DiabetesClassification of Diabetes

    Type 1 diabetes -cell destruction

    Type 2 diabetes

    Progressive insulin secretory defect

    Other specific types of diabetes

    Genetic defects in -cell function, insulin action

    Diseases of the exocrine pancreas

    Drug- or cheical-induced

    Gestational diabetes ellitus !GD"#

    $D$% &% 'lassification and Diagnosis% Diabetes 'are 2(1)*+!suppl 1#.1)

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    18/42

    (eport o the E'pert Committee on the Diagnosis

    and Classifcation o Diabetes )ellitus$ DiabetesCare *++, *./0uppl 12!s3-s*+

    T+(e Diabe!e#

    (esults rom autoimmune destructiono pancreatic beta-cells

    Absolute insulin defciency

    %atients typically dependent on insulin

    or sur#i#al

    %atients may present with ketoacidosis

    as initial sign o the disorder

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    19/42

    (eport o the E'pert Committee on the Diagnosisand Classifcation o Diabetes )ellitus$ DiabetesCare *++, *./0uppl 12!s3-s*+

    T+(e 7 Diabe!e#

    Insulin resistance and relati#e insulindefciency

    %atients may or may not need insulin

    treatment to sur#i#e )ay remain undiagnosed or many years" as

    hyperglycemia de#elops slowly

    Associated with strong genetic predispositio 4eterogenous

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    20/42

    G&%#e5$g:'&6

    1; ;;

    1;

    7;;

    71;

    DeGr%%! an' >L >a$e#%n. P*i&a'e&(*ia? 9.B. San'er# C%., 7;;.Origina&&+ (b&i#*e' in Type 2 Diabetes BASICS. 5In!erna!i%na& Diabe!e# Cen!er, Minnea(%&i#, 7;;;6.

    Re&a!i"e)n!i%n

    5@6

    Fa#!ingg&%#e

    ObesityObesity IFGIFG DiabetesDiabetesUncontrolledUncontrolled

    hyperglycemiahyperglycemia

    In#&in re#i#!ane

    P%#!-(ran'ia&g&%#e

    In#&in #ere!i%nClinicalClinicaldiagnosisdiagnosis

    Natural History of Type 2 DiabetesNatural History of Type 2 Diabetes

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    21/42

    (eport o the E'pert Committee on the Diagnosis and Classifcation o Diabetes )ellitus$ Diabetes Care *++,

    *./0uppl 12!s3-s*+

    Ge#!a!i%na& Diabe!e# Me&&i!#

    5GDM6 Any degree o glucose intolerance with

    onset or frst recognition during

    pregnancy Associated with increased perinatal

    morbidity and mortality

    . weeks or more ater pregnancy ends"the woman should be reclassifed

    4igh risk or type * D)$

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    22/42

    (eport o the E'pert Committee on the Diagnosis and Classifcation o Diabetes )ellitus$ Diabetes Care *++,

    *./0uppl 12!s3-s*+

    Ge#!a!i%na& Diabe!e# Me&&i!#5GDM6

    RIS FACTORS5Maternal age + 3, (ears5Mar-ed obesit(5ersonal histor( of /DM

    5reious infant + * -g5re)diabetes5/l(cosuria5#trong famil( histor( of DM51(pertension before pregnanc(

    or in earl( pregnanc(5Ethnicracial group ith high prealence of DM "&frican)&mericans4 &sian)&mericans4 1ispanic)&mericans4 5atie

    &mericans4 acific 6slanders%

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    23/42

    DETECTION AND DIAGNOSISDETECTION AND DIAGNOSISOF GESTATIONAL DIABETESOF GESTATIONAL DIABETES

    MELLITUS (GDM)MELLITUS (GDM)

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    24/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    25/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    26/42

    Routine Prenatal Care ScreeningTwo Step Approach

    50 gm random

    oral glucose load

    !hour plasma glucose

    measurement

    "#$0 mg%dl

    00 &RA'S

    (&TT

    1st

    step

    2nd step

    GDM Di i

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    27/42

    GDM Diagn%#i#

    7 A((r%a*e# )%r Diagn%#ing Ge#!a!i%na& Diabe!e# Me&&i!# 5GDM6AACE- and ADA-recommended

    1-step 63-g *-hour oral glucose tolerance test /789921"*or

    AC78-recommended

    * steps! a 3+-g 1-hour glucose challenge test /8C92" ollowed bya 1++-g ,-hour 7899 /i necessary2,

    GDM Diagnostic Criteria for OGTT Testing7,)g 2)hour8 $00)g 3)hour9

    asting plasma glucose"/%

    ;0 mgd= "$0.0 mmol=%2 ;$>0 mgd= "$0.0 mmol=%2

    2)hour post)challengeglucose

    ;$,3 mgd= ">., mmol=2 ;$,, mgd= ">.! mmol=%2

    3)hour post)challengeglucose

    ;$*0 mgd= "7.> mmol=%2

    8& positie diagnosis re?uires that test results satisf( an( one of these criteria9& positie diagnosis re?uires that ;2 thresholds are met or exceeded

    1.AACE.Endocr Pract

    . 2011;17(2):1-53.2.ADA.Diabetes Care. 2013;36(suppl 1):11-66.3.Committee on Obstetric Practice. ACOG. 2011;504:1-3.

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    28/42

    TESTING FOR DIABETES INTESTING FOR DIABETES INASYMTOMATIC ATIENTSASYMTOMATIC ATIENTS

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    29/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    30/42

    % ge! a gre %) ;;-71$g:'&, +% are 4i!e range %) IFG --- a %n'i!i%n 4*i* $a+ !aei!!&e !i$e !% 'e"e&%( in!% )ran 'iabe!e#. In #a#e %n#&! a %$(e!en! 'iabe!e# &ini

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    31/42

    I) +% ge! a gre %) 7$g:'& an'%"er, %n#&!

    a %$(e!en! 'iabe!e# &ini )%r%nr$a!i%n

    an' !rea!$en!. Y% (r%bab&+ are'iabe!i.

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    32/42

    T*e be#! 4a+ !% (re"en! 'iabe!e# in*ig* ri#

    in'i"i'a an' !% (re"en!%$(&ia!i%n# a$%ng

    %nr$e' 'iabe!i# i# !% %n#i#!en!&+ee(

    FBS be&%4 ;; 7$g:'& re#(e!i"e&+an' PBG be&%4 =;$g:'&.

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    33/42

    Eeri#e 'ai&+

    D%n! ge! )a! %r %"er4eig*!

    ee( in !%* 4i!* a g%%' 'iabe!e# &in

    %i' #4ee!#, #a&!, )a!, a&%*%& an' igare

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    34/42

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    35/42

    I!" RE!ENTION#DELAY OFI!" RE!ENTION#DELAY OFTYE $ DIABETESTYE $ DIABETES

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    36/42

    ADA 7;;/? E(er! C%$$i!!ee Re%$$en'# U#e%) 8e$%g&%bin AC )%r Diagn%#i# %) Diabe!e#

    :une 6" *++; /" and EA0D ?oined orces to

    recommend the use o A1c assay or thediagnosis o diabetes

    Diagnostic #alue o @.$3

    9his cut-point is where risk oretinopathy substantially increases

    Cri!eria )%r !*e Diagn%#i# %)Cri!eria )%r !*e Diagn%#i# %)

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    37/42

    Cri!eria )%r !*e Diagn%#i# %)Cri!eria )%r !*e Diagn%#i# %)

    Diabe!e#Diabe!e#

    AC H.1@

    9he test should be perormed in alaboratory using an

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    38/42

    Pre'iabe!e#? IFG, IGT, Inrea#e'Pre'iabe!e#? IFG, IGT, Inrea#e'ACAC

    Ca!eg%rie# %) inrea#e' ri# )%r 'iabe!e#5Pre'iabe!e#6

    >%8 1++-1*3 mgdl /3$.-.$; mmoll2! I>8

    or

    *-h plasma glucose in the 63-g 78991+-1;; mgdl /6$F-11$+ mmoll2! I89

    or

    A1C 3$6-.$

    >or all three tests" risk is continuous" e'tending below the lower limit o a range and becomingdisproportionately greater at higher ends o the range$

    $D$% &% 'lassification and Diagnosis% Diabetes Care 2(11*+)!suppl 1#.1+% Table +%

    Cl ifi ti f D

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    39/42

    Classification of D

    NDDG !"#$#%

    "& D Type I' Insulin'dependent diabetes mellitus

    !IDD%

    2& Type II Non'insulin'

    dependent D !NIDD%

    (& Gestational diabetes

    )& alnutrition related diabetes

    *& Other type of D

    Impaired glucose tolerance

    !IGT%

    '

    +D+ !"##$%

    "& Type " diabetes!'cell

    destruction%

    a& Immune mediated

    b& Idiopathic

    2& Type 2 diabetes !insulin

    resistance , insulin

    deficient%

    (& Gestational diabetes

    )& Other specific types

    C& i i ) Di b

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    40/42

    C&a##ia!i%n %) Diabe!e#C&a##ia!i%n %) Diabe!e#

    T+(e 'iabe!e#

    K-e&& 'e#!r!i%n

    T+(e 7 'iabe!e#

    Pr%gre##i"e in#&in #ere!%r+ 'e)e!

    O!*er #(ei !+(e# %) 'iabe!e#

    Gene!i 'e)e!# in K-e&& )n!i%n, in#&in a!i%n

    Di#ea#e# %) !*e e%rine (anrea# 5+#!i

    br%#i#, (anrea!i!i#6 Drg- %r *e$ia&-in'e' 5!rea!$en! %) AIDS %r

    a)!er %rgan !ran#(&an!a!i%n6

    Ge#!a!i%na& 'iabe!e# $e&&i!#$D$% &% 'lassification and Diagnosis% Diabetes Care2(11*+)!suppl 1#.12%

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    41/42

    8+(%!*e!ia& S!age# in !*e De"e&%($en! %)T+(e Diabe!e# 5Fr%$ Gene!i S#e(!ibi&i!+

    !% -e&& De#!r!i%n6

    PrecipitatingAgent

    Age (years)

    Beta

    cell

    mass

    Genetic

    predisposition

    Overt

    immnologica!normalities

    N insulinrelease

    Progressiveloss inslinrelease

    GlucoseNormal

    OvertDia!etes

    C-peptide

    present

    No C-peptide

    Type 1 diabetes occurs individuals in whom genetic susceptibility outweighs genetic protection

    GDM 'iagn%#!i !*re#*%&' "a&e# )r%$

  • 7/24/2019 Classification and Diagnosis of Dm Isd Workshop 2014

    42/42

    GDM 'iagn%#!i !*re#*%&' "a&e# )r%$"ari%# %rgania!i%n

    -*%r

    P&a#$a g&%#e %nen!ra!i%n!*re#*%&'# 5$g:'&6

    Organia!i%n OGTTg&%#e

    &%a'

    Fa#!ing

    ADA/Carpenter G

    Coustan2